MARKET WIRE NEWS

Expected earnings - SELLAS Life Sciences Group Inc.

Source: US Earnings Reports
SELLAS Life Sciences Group Inc. (SLS) is expected to report for Q2 2025
SELLAS Life Sciences Group Inc.

NASDAQ: SLS

SLS Trading

20.38% G/L:

$6.97 Last:

7,820,479 Volume:

$6.48 Open:

mwn-ts Ad 300

SLS Latest News

May 13, 2026 09:33:01 am
Chasing the Next Explosive Small-Cap Run

SLS Stock Data

$535,597,063
140,448,048
1.12%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
New York

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App